| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Medicine, Department of Veterans Affairs Medical Center, San Diego, 92161; and University of California, San Diego, California 92037
The aim of this study was to investigate the regulation of the 5-lipoxygenase pathway of arachidonic acid metabolism by lymphocytes using the monocyte-like cell line, THP-1. When THP-1 cells were incubated over 4-7 days in 10% supernatant from lectin-activated human lymphocytes, their capacity to synthesize 5-lipoxygenase products was significantly increased. In contrast, the supernatant from nonactivated lymphocytes had no effect. The increase in capacity to synthesize 5-lipoxygenase products was mimicked by the addition of either granulocyte macrophage colony-stimulating factor (GM-CSF) or interleukin-3. These increases in synthetic capacity reflected increased enzymatic activity. Increased immunoreactive protein and mRNA for the enzymes 5-lipoxygenase and 5-lipoxygenase-activating protein were also found in cells conditioned with activated lymphocyte supernatants. Furthermore, the increase in mRNA for both enzymes was not blocked by cycloheximide, suggesting that the effect on steady-state mRNA levels does not require the synthesis of new protein. The increase in mRNA could be reproduced by GM-CSF. We conclude that lymphocytes can regulate the expression of 5-lipoxygenase in THP-1 cells over a period of days via the release of soluble factors.
arachidonic acid; leukotrienes; inflammation; cytokines; 5-lipoxygenase-activating protein
This article has been cited by other articles:
|
|
 |
|
  A. Klegeris and P. L. McGeer Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP J. Leukoc. Biol., March 1, 2003; 73(3): 369 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Serio, S. C. Johns, L. Luo, C. R. Hodulik, and T. D. Bigby Lipopolysaccharide Down-Regulates the Leukotriene C4 Synthase Gene in the Monocyte-Like Cell Line, THP-1 J. Immunol., February 15, 2003; 170(4): 2121 - 2128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Chu, L.-O. Tang, E. Watney, E. Y. Chi, and W. R. Henderson Jr. In Situ Amplification of 5-Lipoxygenase and 5-Lipoxygenase-Activating Protein in Allergic Airway Inflammation and Inhibition by Leukotriene Blockade J. Immunol., October 15, 2000; 165(8): 4640 - 4648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Coffey, S. M. Phare, S. Cinti, M. Peters-Golden, and P. H. Kazanjian Granulocyte-Macrophage Colony-Stimulating Factor Upregulates Reduced 5-Lipoxygenase Metabolism in Peripheral Blood Monocytes and Neutrophils in Acquired Immunodeficiency Syndrome Blood, December 1, 1999; 94(11): 3897 - 3905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Cowburn, S. T. Holgate, and A. P. Sampson IL-5 Increases Expression of 5-Lipoxygenase-Activating Protein and Translocates 5-Lipoxygenase to the Nucleus in Human Blood Eosinophils J. Immunol., July 1, 1999; 163(1): 456 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Riddick, K. J. Serio, C. R. Hodulik, W. L. Ring, M. S. Regan, and T. D. Bigby TGF-{beta} Increases Leukotriene C4 Synthase Expression in the Monocyte-Like Cell Line, THP-1 J. Immunol., January 15, 1999; 162(2): 1101 - 1107. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
